SusanHTannenbaumMD
Oncology • Farmington, CTAssociate Professor, Medicine, University of Connecticut SOM
Are you Dr. Tannenbaum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
263 Farmington Ave
Farmington, CT 06030Phone+1 860-679-2100Fax+1 860-679-4815
Summary
- Dr. Susan Tannenbaum, MD is an oncologist in Farmington, Connecticut. She is currently licensed to practice medicine in Connecticut, California, and Maryland. She is affiliated with UConn, John Dempsey Hospital and is an Associate Professor at University of Connecticut SOM.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1982 - 1986
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1978 - 1982
State University of New York Downstate Medical Center College of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1996 - Present
CT State Medical License 2003 - 2025
MD State Medical License 1990 - 1997
PA State Medical License 1984 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Optical Tomography With Ultrasound Guidance Start of enrollment: 2007 Apr 01
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer Start of enrollment: 2010 May 26
- Join now to see all
Publications & Presentations
PubMed
- 695 citationsIdentification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an a...Hiroshi Nagata, Alexandra S. Worobec, Chad K. Oh, Badrul A. Chowdhury, Susan Tannenbaum
Proceedings of the National Academy of Sciences of the United States of America. 1995-11-07 - 22 citationsA Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence.Marcia V. Fournier, Edward C. Goodwin, Joan Chen, John C. Obenauer, Susan Tannenbaum
Scientific Reports. 2019-10-16 - 23 citationsRandomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitor...Kerin B. Adelson, Bhuvaneswari Ramaswamy, Joseph A. Sparano, Paul J. Christos, John J. Wright
NPJ Breast Cancer. 2016-12-14
Press Mentions
Battling Stage 4 Breast Cancer for 4 Years: ‘I Have Cancer, but Cancer Does Not Have Me’November 18th, 2022- Battling Stage 4 Breast Most Cancers for 4 Years: ‘I Have Most Cancers, However Most Cancers Does Not Have Me’November 18th, 2022
- UConn Doctors Provide Lung Cancer Screenings for CommunityNovember 18th, 2021
- Join now to see all
Grant Support
- StressorsNational Center For Research Resources2008
